Eris Lifesciences Limited — Call Transcript 2020

Oct 29, 2020

==> picture [596 x 69] intentionally omitted <==

==> picture [596 x 69] intentionally omitted <==

Date: 29[th] October, 2020

To BSE Limited Phiroze Jeejeebhoy Towers Dalal Street Mumbai- 400001	To National Stock Exchange of India Limited Exchange Plaza Bandra Kurla Complex Bandra (E) Mumbai-400051
Security Code: 540596	Symbol: ERIS

SUBJECT: : INTIMATION OF SCHEDULE OF ANALYST & INVESTOR CALL PURSUANT TO REGULATION 30 AND OTHER APPLICABLE REGULATIONS OF THE SECURITIES AND EXCHANGE BOARD OF INDIA (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2015 (SEBI LODR, 2015)

Dear Sir/Madam,

This is further to our letter dated 27[th] October, 2020 intimating about the date of the Board Meeting to consider Unaudited Financial Results for the quarter and half year ended 30[th] September, 2020 of the Company.

We wish to inform that pursuant to regulation 30 and other applicable regulations, if any, of the SEBI LODR, 2015 the Company will hold a conference call for analysts and investors on Tuesday, 3[rd] November, 2020. The details of the said call are attached herewith and also available on Company’s website.

Thanking You,

For Eris Lifesciences Limited

==> picture [66 x 55] intentionally omitted <==

Milind Talegaonkar Company Secretary & Compliance Officer Membership No.: A26493

Encl: a/a

==> picture [596 x 4] intentionally omitted <==

==> picture [596 x 4] intentionally omitted <==

==> picture [596 x 4] intentionally omitted <==

==> picture [596 x 4] intentionally omitted <==

==> picture [596 x 4] intentionally omitted <==

==> picture [596 x 4] intentionally omitted <==

==> picture [596 x 4] intentionally omitted <==

==> picture [596 x 4] intentionally omitted <==

==> picture [596 x 4] intentionally omitted <==

==> picture [596 x 4] intentionally omitted <==

==> picture [596 x 4] intentionally omitted <==

==> picture [596 x 4] intentionally omitted <==

==> picture [596 x 4] intentionally omitted <==

==> picture [596 x 4] intentionally omitted <==

==> picture [596 x 4] intentionally omitted <==

==> picture [596 x 5] intentionally omitted <==

==> picture [596 x 4] intentionally omitted <==

==> picture [596 x 4] intentionally omitted <==

==> picture [596 x 4] intentionally omitted <==

==> picture [596 x 4] intentionally omitted <==

==> picture [596 x 4] intentionally omitted <==

==> picture [101 x 58] intentionally omitted <==

The Senior Management Team of

Eris Lifesciences Limited

Cordially invites you to its

Earnings Conference Call

To discuss the financial and operational performance for

Q2 & H1 FY21

Day/Date: Tuesday, 3[rd] November, 2020

Time: 4:30 PM, IST

Option 1: Express Join with Diamond Pass[TM]

• Pre-register with the below link and join without waiting for the operator: https://services.choruscall.in/DiamondPassRegistration/register?confirmationNumber=6550453&linkSecurity

String=12cc242929

Option 2: Join through below Dial-In Numbers

Access Numbers

+91 22 6280 1472 Primary Number: +91 22 7115 8839 Local Dial-in +91- 70456 71221

USA: 1 866 746 2133 UK: 0 808 101 1573 Singapore: 800 101 2045 Hong Kong: 800 964 448 Argentina: 008 001 424 3444 Australia: 180 005 3698 Belgium: 008 001 424 3444 Canada: 0 118 001 424 3444 China: 400 842 8405 France: 080 091 4745 International Toll Free Number: Germany: 008 001 424 3444 Italy: 008 001 424 3444 Japan: 005 311 61110 Netherlands: 0 800 022 9808 Poland: 0 0800 112 4248 South Korea: 0 018 001 424 3444 Sweden: 008 001 424 3444 Switzerland: 080 056 4911 Thailand: 0 018 001 424 3444

We look forward to your participation RSVP: Kruti Raval : +91 99090 17419